Omind Neurotechnologies
Omind Neurotechnologies offers neuroscience-based workplace assessments and personalized training that measure and improve employees' emotional management, decision-making, and adaptation. The company combines VR experiences, biometric sensors, AI personalization, and multimodal signal processing to deliver experiential neurotraining and behavioral assessments through an all-in-one platform. Its technology stack and assets include a normative multimodal database, VR stimuli libraries, a real-time processing engine (TimeFlux), and an anonymized repository (Quetzal) for research and content. Omind operates as a B2B SaaS provider selling to HR and corporate training teams and publishes scientific research alongside proprietary IP and content.
Omind Neurotechnologies
Omind Neurotechnologies offers neuroscience-based workplace assessments and personalized training that measure and improve employees' emotional management, decision-making, and adaptation. The company combines VR experiences, biometric sensors, AI personalization, and multimodal signal processing to deliver experiential neurotraining and behavioral assessments through an all-in-one platform. Its technology stack and assets include a normative multimodal database, VR stimuli libraries, a real-time processing engine (TimeFlux), and an anonymized repository (Quetzal) for research and content. Omind operates as a B2B SaaS provider selling to HR and corporate training teams and publishes scientific research alongside proprietary IP and content.
TL;DR
Headquarters & founding: Paris; founded 2016
Product: Neuroscience- and AI-driven multimodal assessments and immersive (including VR) neurotraining for enterprises
Business model: B2B SaaS selling to HR and corporate training teams
Tech & assets: VR experiences, biometric sensors, AI personalization, TimeFlux real-time engine, normative multimodal database
Funding signal: Seed round announced Apr 17, 2022; investors listed include Bpifrance and Agence de Développement de la Normandie
Company Overview
Problem Domain
Leadership development, talent assessment, behavioral upskilling, and corporate training effectiveness measurement
Founded
2016
Industry
Biotechnology
Tech Stack
Funding Track Record
Seed round announced Apr 17, 2022; amount not disclosed in cited profiles
Investor Signal
“Investors listed include Agence de Développement de la Normandie and Bpifrance”